The main goal of the present study was to evaluate the IDH1-related incidence of AML in newly diagnosed adult Chinese AML patients, as well as explore the correlation between IDH1 mutations and the clinical index, cytogenetics, molecular biology or prognosis. This evidence concerns the gene IDH1 and acute myeloid leukemia.